Vycor Medical Financials
| VYCO Stock | USD 0.07 0 1.45% |
With this module, you can analyze Vycor financials for your investing period. You should be able to track the changes in Vycor Medical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Vycor |
The data published in Vycor Medical's official financial statements typically reflect Vycor Medical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Vycor Medical's quantitative information. For example, before you start analyzing numbers published by Vycor accountants, it's essential to understand Vycor Medical's liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
Vycor Medical Stock Summary
Vycor Medical competes with Neuropace, Delcath Systems, SurModics, and CVRx. Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Vycor Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 6 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 951 Broken Sound |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.vycormedical.com |
| Phone | 561 558 2000 |
| Currency | USD - US Dollar |
Vycor Medical Key Financial Ratios
Vycor Medical's financial ratios allow both analysts and investors to convert raw data from Vycor Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Vycor Medical over time and compare it to other companies across industries.| Return On Asset | -0.24 | |||
| Beta | 1.31 | |||
| Z Score | -23.4 |
Vycor Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vycor Medical's current stock value. Our valuation model uses many indicators to compare Vycor Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vycor Medical competition to find correlations between indicators driving Vycor Medical's intrinsic value. More Info.Vycor Medical is rated third in return on asset category among its peers. It is rated third in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vycor Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vycor Medical's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Vycor Medical Systematic Risk
Vycor Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vycor Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Vycor Medical correlated with the market. If Beta is less than 0 Vycor Medical generally moves in the opposite direction as compared to the market. If Vycor Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vycor Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vycor Medical is generally in the same direction as the market. If Beta > 1 Vycor Medical moves generally in the same direction as, but more than the movement of the benchmark.
Vycor Medical December 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vycor Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vycor Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vycor Medical based on widely used predictive technical indicators. In general, we focus on analyzing Vycor OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vycor Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 22.16 | |||
| Information Ratio | 0.0433 | |||
| Maximum Drawdown | 86.27 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 15.79 |
Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.